pharmaphorum

APRIL 26, 2021

Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder. The post Jolly Good/Teijin Pharma develop VR digital therapeutics for depression appeared first on.

Hospitals 122

Hospitals 122

PharmaShots

JANUARY 27, 2023

Magenta Therapeutics Pauses the P-I/II Study in AML Patients Date: Jan 27, 2023 | Tags: Magenta Therapeutics, MGTA-117, AML, Clinical Trial, P-I/II Ipsen Receives CHMP Negative Opinion for Palovarotene to Treat Fibrodysplasia Ossificans Progressiva Date: Jan 27, 2023 | Tags: Ipsen, Palovarotene, Fibrodysplasia Ossificans Progressiva, Regulatory, CHMP, (..)

FDA 40

FDA Immunization 40

pharmaphorum

AUGUST 21, 2022

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity (formerly AXS-05) – a year after its approval was held up by the regulator. The post Axsome bounces back as FDA clears depression drug appeared first on. Photo by Sydney Sims on Unsplash.

FDA 98

FDA Labelling 98

pharmaphorum

NOVEMBER 24, 2022

Johnson & Johnson’s Spravato therapy for treatment-resistant depression (TRD) hasn’t made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate its take-up. Both drugs were given on top of standard antidepressants to patients wo had failed a least two earlier treatments.

Labelling 52

Labelling Hospitals 52

The Checkup by Singlecare

MARCH 21, 2023

These alternative prescription medications include other types of opioids , NSAIDs like Advil or Motrin ( ibuprofen ) or Aleve ( naproxen ), and some medications used for depression or seizures, like Cymbalta (duloxetine) or gabapentin. mg to 2 mg every 4 hours as needed – adjust according to response IM, SubQ: 0.2

Dosage 52

Dosage Controlled Substances Labelling Packaging 52

The Checkup by Singlecare

MAY 8, 2023

In addition to typical side effects seen with opioids, such as sedation and respiratory depression, the side effects of tramadol also include seizures and low blood sugar, among others. This is also beneficial as it allows for a wider safety margin; certain effects, like respiratory depression, also plateau despite increasing doses.

Controlled Substances 52

Controlled Substances Dosage Labelling FDA 52